Usnic acid improves memory impairment after cerebral ischemia/reperfusion injuries by anti-neuroinflammatory, anti-oxidant, and anti-apoptotic properties.
Apoptosis
Cerebral ischemia
Lichen secondary-metabolites
Neuroinflammation
Spatial memory
Journal
Iranian journal of basic medical sciences
ISSN: 2008-3866
Titre abrégé: Iran J Basic Med Sci
Pays: Iran
ID NLM: 101517966
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
entrez:
23
9
2020
pubmed:
24
9
2020
medline:
24
9
2020
Statut:
ppublish
Résumé
Cerebral ischemia/reperfusion causes complex pathological mechanisms that lead to brain tissue damage. Usnic acid is a lichen secondary metabolite that has many different biological properties including anti-inflammatory and anti-oxidant activities. Therefore, the objective of the current study was to investigate the neuroprotective effects of usnic acid on apoptotic cell death, neuroinflammation, anti-oxidant enzyme activities, and oxidative stress levels after transient cerebral ischemia/reperfusion. Forty-two male Wistar rats were randomly assigned to three groups (sham, ischemia/reperfusion, and ischemia/reperfusion+usnic acid). Ischemia was induced by 20 min occlusion of common carotid arteries. Injection of usnic acid (25 mg/kg, intraperitoneally) and saline was done at the beginning of reperfusion time. Morris water maze was applied to assess spatial memory. The protein expression amount was measured using immunohistochemical and immunofluorescence staining. Spectrophotometric assay was performed to determine the levels of anti-oxidant enzymes. Usnic acid significantly reduced caspase-3, glial fibrillary acidic protein- positive and ionized calcium-binding adaptor molecule 1-positive cells ( Our findings indicate that usnic acid has neuroprotective properties, which possibly is applicable as a promising candidate for cerebral injuries caused by ischemia.
Identifiants
pubmed: 32963745
doi: 10.22038/ijbms.2020.43280.10165
pmc: PMC7491502
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1225-1231Références
J Pharm Biomed Anal. 2010 Oct 10;53(2):165-71
pubmed: 20457504
J Physiol Sci. 2015 Sep;65(5):435-43
pubmed: 26012958
Redox Biol. 2017 Aug;12:216-225
pubmed: 28259102
Brain Pathol. 2000 Apr;10(2):283-92
pubmed: 10764048
J Ethnopharmacol. 2006 Jan 3;103(1):59-65
pubmed: 16169175
Iran J Basic Med Sci. 2019 Jun;22(6):617-622
pubmed: 31231488
Int Immunopharmacol. 2014 Oct;22(2):371-8
pubmed: 25068825
J Neurosci Res. 2009 Jan;87(1):112-22
pubmed: 18711744
Basic Clin Neurosci. 2016 Jan;7(1):21-9
pubmed: 27303596
Neurosci Biobehav Rev. 1996 Autumn;20(3):445-52
pubmed: 8880734
Stroke. 2011 Sep;42(9):2672-713
pubmed: 21778438
Neuropathol Appl Neurobiol. 2015 Jun;41(4):544-56
pubmed: 24750178
PLoS One. 2013 Oct 25;8(10):e78163
pubmed: 24205142
Naturwissenschaften. 2002 Apr;89(4):137-46
pubmed: 12061397
Food Chem Toxicol. 2017 Jul;105:262-277
pubmed: 28450128
Brain Behav. 2016 Mar 22;6(4):e00449
pubmed: 27127723
Neural Regen Res. 2015 Aug;10(8):1245-50
pubmed: 26487851
Neurochem Res. 2018 Dec;43(12):2252-2259
pubmed: 30259275
J Mol Neurosci. 2018 Jul;65(3):377-384
pubmed: 29956089
Iran J Basic Med Sci. 2018 Jan;21(1):53-58
pubmed: 29372037
Cell. 2008 May 16;133(4):693-703
pubmed: 18485876
Pharm Biol. 2016;54(1):1-17
pubmed: 25885942
J Physiol Sci. 2017 Jan;67(1):163-171
pubmed: 27099131
Neuropeptides. 2015 Feb;49:63-8
pubmed: 25617953
J Stroke. 2017 May;19(2):166-187
pubmed: 28480877
PLoS One. 2017 Dec 8;12(12):e0189211
pubmed: 29220411
FEMS Microbiol Lett. 2014 Apr;353(1):57-62
pubmed: 24571086
Exp Neurobiol. 2016 Oct;25(5):241-251
pubmed: 27790058
Stroke. 2008 Mar;39(3):935-42
pubmed: 18258827
Evid Based Complement Alternat Med. 2017;2017:7392891
pubmed: 29348773
Ann N Y Acad Sci. 2010 Oct;1207:149-54
pubmed: 20955438